Search Results
Results found for "Gregory Stewart"
- 📰 GPCR Weekly News, July 1 to 7, 2024
of GPCR-G protein selectivity revealed by structural pharmacology Yao Lu, Drs Christopher Langmead, Gregory Stewart, et al. for their study on Molecular insights into orphan G protein-coupled receptors relevant
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
activity-modifying proteins in obesity and diabetes mellitus Maleesha Ubhayarathna , Christopher Langmead , Gregory Stewart , et al. for their fantastic review on Molecular and structural insights into the 5-HT2C receptor
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Jan Steyaert will be presented with the Gabbay Award at Brandeis University on October 27 when he will This award recognizes the combination of Steyaert’s fundamental research and his ability to apply the Steyaert bridged fundamental high-impact research in biomedical sciences with the mechanistic understanding
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
It means a commitment to continuous improvement — starting with the highest-friction gaps and working
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
September 2022 To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started
- 📰 GPCR Weekly News, September 4 to 10, 2023
Gregory Tall and team's study on GPR114/ADGRG5, activated by tethered-peptide-agonist, a cleaved adhesion
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
L., Gregory, K. J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L. T. (2016).
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne , Cam Sinh Lu , Karen Gregory
- Targeting Intracellular Allosteric Sites in GPCRs
a single compound, resulting in a novel category of GPCR ligands referred to as 'bitopic' (Valant, Gregory
- Nanobodies: New Dimensions in GPCR Signaling Research
This provides a better starting point for the crystallization of intrinsically unfolded proteins. K., & Steyaert, J. (2017). Nanobodies to Study G Protein-Coupled Receptor Structure and Function. H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). D., Tworak, A., Watanabe, K., Pardon, E., Steyaert, J., Kandori, H., Katayama, K., Kiser, P.
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Using these results as a starting point, the Tag-lite® binding assay was developed. M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.







